Page last updated: 2024-08-17

quinoxalines and Trypanosomiasis, African

quinoxalines has been researched along with Trypanosomiasis, African in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agnamey, P; Azas, N; Cohen, A; Daulouede, S; Del Favero, M; Farvacques, N; Guillon, J; Hutter, S; Le Pape, P; MulliƩ, C; Pagniez, F; Pinaud, N; Ronga, L; Savrimoutou, S; Sonnet, P; Soum, C; Vincendeau, P1

Other Studies

1 other study(ies) available for quinoxalines and Trypanosomiasis, African

ArticleYear
Design, synthesis and biological evaluation of novel 4-alkapolyenylpyrrolo[1,2-a]quinoxalines as antileishmanial agents--part III.
    European journal of medicinal chemistry, 2014, Jun-23, Volume: 81

    Topics: Animals; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Female; Hep G2 Cells; Humans; Leishmania; Macrophages; Mice; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinoxalines; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African

2014